{"title":"用于真菌感染的局部溶酶体凝胶的研制与评价。","authors":"Preeti Gupta, Abdul Hafeez, Poonam Kushwaha","doi":"10.1055/a-1924-7818","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Fungal infections are one of the most common dermatological issues worldwide. Candida species-caused fungal infections are frequent on the cutaneous surface. Eberconazole (EBZ) has the strongest antifungal action against Candida spp., the major source of fungal infections.</p><p><strong>Method: </strong>In the present study, the cold method followed by probe sonication was used to create EBZ-loaded ethosomal dispersion. The solubility of ethosomes in different lipids and surfactants was used to choose these components. Under magnetic stirring, the dispersion was absorbed into a carbopol 934 gel. <i>In vitro</i> antifungal activity was performed using the Agar well diffusion method, and their topical effectiveness against pathogenic <i>Candida albicans</i> was compared to that of a marketed formulation containing EBZ.</p><p><strong>Results: </strong>Eberconazol incorporated into gel displayed sustained release in an <i>in vitro</i> release assay. Based on the zone of inhibition diameters, EBZ formulation was determined to be efficient against <i>C. albicans</i> when compared to the commercialized cream and plain gel.</p><p><strong>Conclusion: </strong>Based on these findings, the current study found that EBZ possesses significant antifungal efficacy against <i>C. albicans</i>.</p>","PeriodicalId":11451,"journal":{"name":"Drug Research","volume":null,"pages":null},"PeriodicalIF":1.7000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Development and Evaluation of Topical Ethosomal Gel for Fungal Infections.\",\"authors\":\"Preeti Gupta, Abdul Hafeez, Poonam Kushwaha\",\"doi\":\"10.1055/a-1924-7818\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Fungal infections are one of the most common dermatological issues worldwide. Candida species-caused fungal infections are frequent on the cutaneous surface. Eberconazole (EBZ) has the strongest antifungal action against Candida spp., the major source of fungal infections.</p><p><strong>Method: </strong>In the present study, the cold method followed by probe sonication was used to create EBZ-loaded ethosomal dispersion. The solubility of ethosomes in different lipids and surfactants was used to choose these components. Under magnetic stirring, the dispersion was absorbed into a carbopol 934 gel. <i>In vitro</i> antifungal activity was performed using the Agar well diffusion method, and their topical effectiveness against pathogenic <i>Candida albicans</i> was compared to that of a marketed formulation containing EBZ.</p><p><strong>Results: </strong>Eberconazol incorporated into gel displayed sustained release in an <i>in vitro</i> release assay. Based on the zone of inhibition diameters, EBZ formulation was determined to be efficient against <i>C. albicans</i> when compared to the commercialized cream and plain gel.</p><p><strong>Conclusion: </strong>Based on these findings, the current study found that EBZ possesses significant antifungal efficacy against <i>C. albicans</i>.</p>\",\"PeriodicalId\":11451,\"journal\":{\"name\":\"Drug Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1055/a-1924-7818\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/a-1924-7818","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Development and Evaluation of Topical Ethosomal Gel for Fungal Infections.
Background: Fungal infections are one of the most common dermatological issues worldwide. Candida species-caused fungal infections are frequent on the cutaneous surface. Eberconazole (EBZ) has the strongest antifungal action against Candida spp., the major source of fungal infections.
Method: In the present study, the cold method followed by probe sonication was used to create EBZ-loaded ethosomal dispersion. The solubility of ethosomes in different lipids and surfactants was used to choose these components. Under magnetic stirring, the dispersion was absorbed into a carbopol 934 gel. In vitro antifungal activity was performed using the Agar well diffusion method, and their topical effectiveness against pathogenic Candida albicans was compared to that of a marketed formulation containing EBZ.
Results: Eberconazol incorporated into gel displayed sustained release in an in vitro release assay. Based on the zone of inhibition diameters, EBZ formulation was determined to be efficient against C. albicans when compared to the commercialized cream and plain gel.
Conclusion: Based on these findings, the current study found that EBZ possesses significant antifungal efficacy against C. albicans.
期刊介绍：
Drug Research (formerly Arzneimittelforschung) is an international peer-reviewed journal with expedited processing times presenting the very latest research results related to novel and established drug molecules and the evaluation of new drug development. A key focus of the publication is translational medicine and the application of biological discoveries in the development of drugs for use in the clinical environment. Articles and experimental data from across the field of drug research address not only the issue of drug discovery, but also the mathematical and statistical methods for evaluating results from industrial investigations and clinical trials. Publishing twelve times a year, Drug Research includes original research articles as well as reviews, commentaries and short communications in the following areas: analytics applied to clinical trials chemistry and biochemistry clinical and experimental pharmacology drug interactions efficacy testing pharmacodynamics pharmacokinetics teratology toxicology.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
